A plant-based delivery system for anti-cancer drugs

August 18, 2017, Society for Experimental Biology and Medicine

An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August, 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs. The study, led by Dr. Nicole Steinmetz in the Department of Biomedical Engineering at the Case Western Reserve University Schools of Engineering and Medicine in Cleveland, OH demonstrates that a complex consisting of tobacco mosaic virus and vcMMAE, a first-line chemotherapy agent for the treatment of lymphoma, can kill cancer cells.

Over 800,000 Americans are living with or in remission from lymphoma, a cancer of the lymph system. Non-Hodgkin's lymphoma (NHL) is the most common type of lymphoma, and patients with this disease have a poor prognosis. The first-line treatment strategy for NHL is chemotherapy. However, this approach is associated with off-target side effects. Nanocarriers are being developed to improve drug delivery and minimize off-target effects associated with . However, the utility of many of these systems in drug delivery may be limited by their spherical shape. Elongated nanomaterials may be superior to their spherical counterparts due to increased target cell interactions and decreased immune cell uptake. Nonetheless, the synthesis of highly uniform elongated nanomaterials is challenging,

The current study used a naturally derived assembly containing components of the plant virus (TMV) to overcome issues associated with synthetic systems. TMV was bioconjugated with a valine-citrulline monomethyl auristatin E (vcMMAE) pro-drug used in treating NHL. The resulting TMVvcMMAE complex entered NHL where it was cleaved to release the active drug and killed the cancer cells. Dr. Steinmetz said "Each platform technology offers unique advantages for drug delivery; plant virus-based nanotechnologies can be manufactured in high yields through molecular farming in plants, the protein-based materials are stable in biological media and the biocompatible nanoscale scaffold offers an unparalleled opportunity for engineering allowing the introduction of various medical cargo. While still early in their development stages, plant virus-based drug delivery systems offer an intriguing platform technology for next-generation drug delivery."

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said, "Steinmetz and colleagues have utilized the plant virus TMV as a platform for delivering a valine-citrulline monomethyl auristatin E (vcMMAE) pro-drug into an in vitro model of human B-cell NHL. They observed cell uptake, endolysosomal location and possible cleavage of the prodrug, and cell killing. These studies provide impetus for further testing of this system for cancer treatment."

Explore further: Targeting cancer cells with an implantable drug delivery system

More information: Daniel L Kernan et al. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles, Experimental Biology and Medicine (2017). DOI: 10.1177/1535370217719222

Related Stories

Targeting cancer cells with an implantable drug delivery system

April 20, 2017
An article published in Experimental Biology and Medicine (Volume 242, Issue 7, March, 2017) describes a new drug delivery system for the treatment of cancer. The study, led by Dr. Horst A. von Recum from the Department of ...

Cancer researchers look at resistance to targeted therapy in mantle cell lymphoma

June 14, 2017
Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called Ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. ...

Recommended for you

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

By forming clots in tumors, immune cell aids lung cancer's spread

May 24, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.